Cargando…

High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes

Cell-based high-content screening (HCS) assays have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. The time- and cost-effectiveness of HCS assays, combined with the organotypic nature o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grimm, Fabian Alexander, Iwata, Yasuhiro, Sirenko, Oksana, Bittner, Michael, Rusyn, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652224/ https://www.ncbi.nlm.nih.gov/pubmed/26539751 http://dx.doi.org/10.1089/adt.2015.659

Ejemplares similares

High-Content Assays for Characterizing the Viability and Morphology of 3D Cancer Spheroid Cultures
por: Sirenko, Oksana, et al.
Publicado: (2015)

PRIMEval: Optimization and screening of multiplex oligonucleotide assays
por: Conzemius, Rick, et al.
Publicado: (2019)

A chemical–biological similarity-based grouping of complex substances as a prototype approach for evaluating chemical alternatives
por: Grimm, Fabian A., et al.
Publicado: (2016)

Virtual Cell Based Assay simulations of intra-mitochondrial concentrations in hepatocytes and cardiomyocytes
por: Worth, Andrew P., et al.
Publicado: (2017)

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
por: Grafton, Francis, et al.
Publicado: (2021)

Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening
por: Ovics, Paz, et al.
Publicado: (2020)

Multiplexing physical stimulation on single human induced pluripotent stem cell-derived cardiomyocytes for phenotype modulation
por: Kit-Anan, Worrapong, et al.
Publicado: (2021)

Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes
por: Chaudhari, Umesh, et al.
Publicado: (2017)

Cell membrane array fabrication and assay technology
por: Yamazaki, Victoria, et al.
Publicado: (2005)

Interpretation of field potentials measured on a multi electrode array in pharmacological toxicity screening on primary and human pluripotent stem cell-derived cardiomyocytes
por: Tertoolen, L.G.J., et al.
Publicado: (2018)

Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening
por: Sharma, Arun, et al.
Publicado: (2013)

Accurate nanoelectrode recording of human pluripotent stem cell-derived cardiomyocytes for assaying drugs and modeling disease
por: Lin, Ziliang Carter, et al.
Publicado: (2017)

Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity
por: Piersma, Aldert H., et al.
Publicado: (2022)

Identification of juvenility-associated genes in the mouse hepatocytes and cardiomyocytes
por: Jam, Faidruz Azura, et al.
Publicado: (2018)

Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells
por: Holmgren, Gustav, et al.
Publicado: (2015)

MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
por: Chaudhari, Umesh, et al.
Publicado: (2016)

Computational Toxicology: Realizing the Promise of the Toxicity Testing in the 21st Century
por: Rusyn, Ivan, et al.
Publicado: (2010)

High Content Analysis of Human Pluripotent Stem Cell Derived Hepatocytes Reveals Drug Induced Steatosis and Phospholipidosis
por: Pradip, Arvind, et al.
Publicado: (2016)

Color-coded molecular beacons for multiplex PCR screening assays
por: Marras, Salvatore A. E., et al.
Publicado: (2019)

Bioinformatics analysis to screen key genes implicated in the differentiation of induced pluripotent stem cells to hepatocytes
por: Lin, Rui, et al.
Publicado: (2018)

Development of High Content Imaging Methods for Cell Death Detection in Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Mioulane, Maxime, et al.
Publicado: (2012)

Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture
por: Batalov, Ivan, et al.
Publicado: (2015)

Human pluripotent stem cell fate trajectories toward lung and hepatocyte progenitors
por: Ori, Chaido, et al.
Publicado: (2023)

Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
por: Narkar, Akshay, et al.
Publicado: (2022)

A Novel High-Content Screening-Based Method for Anti-Trypanosoma cruzi Drug Discovery Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Portella, Diogo Crispim Nascimento, et al.
Publicado: (2021)

Digital multiplex ligation assay for highly multiplexed screening of β-lactamase-encoding genes in bacterial isolates
por: Tamminen, Manu, et al.
Publicado: (2020)

Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes
por: Chu, Axel J., et al.
Publicado: (2020)

Multiplex Flow Assays
por: Haushalter, Kristofer J., et al.
Publicado: (2016)

Multiplex Screening Assay for Identifying Cytotoxic CD8(+) T Cell Epitopes
por: Poh, Chek Meng, et al.
Publicado: (2020)

“The impact of statins addind to the fixed combination antihypertensive therapy on the arterial stiffness in patients with moderate and severe hypertension"
por: Sirenko, Yuriy, et al.
Publicado: (2023)

Paired image- and FACS-based toxicity assays for high content screening of spheroid-type tumor cell cultures
por: Trumpi, Kari, et al.
Publicado: (2015)

A novel human pluripotent stem cell-based assay to predict developmental toxicity
por: Lauschke, Karin, et al.
Publicado: (2020)

New Modalities of 3D Pluripotent Stem Cell-Based Assays in Cardiovascular Toxicity
por: Orsolits, Barbara, et al.
Publicado: (2021)

High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation
por: de Souza Lima, Ildercílio Mota, et al.
Publicado: (2019)

Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy
por: Chen, Ai-Lan, et al.
Publicado: (2012)

Collagen vitrigel promotes hepatocytic differentiation of induced pluripotent stem cells into functional hepatocyte-like cells
por: Nakai, Shun, et al.
Publicado: (2019)

Generation of human hepatocytes from extended pluripotent stem cells
por: Wang, Qiming, et al.
Publicado: (2020)

A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening
por: Gilbert, Daniel F., et al.
Publicado: (2011)

Drug screening platform using human induced pluripotent stem cell‐derived atrial cardiomyocytes and optical mapping
por: Gunawan, Marvin G., et al.
Publicado: (2020)

Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation
por: Hamledari, Homa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4jb13eu9kdk6qvqq59cnmtpjko